News
Two new cases of resistant gonorrhoea diagnosed in the UK
Public Health England (PHE) is investigating two cases of extensively drug resistant (XDR) gonorrhoea recently diagnosed in the U.K. XDR …
Continue ReadingResistancePlus® GC receives CE-IVD mark
SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its ResistancePlus® GC assay that detects both the sexually …
Continue ReadingJohns Hopkins raising awareness of Mycoplasma genitalium resistance test for reproductive health
Dr. Maria Trent, a Professor of Pediatrics and Public Health at Johns Hopkins Medicine, is spearheading efforts to raise awareness …
Continue ReadingSpeeDx broaden European Distribution Network
SpeeDx have signed of a further four distribution partners, in preparation to strengthen representation across Europe. Axonlab (Germany, Benelux and …
Continue ReadingDraft BASHH gonorrhoea guidelines recommend ciprofloxacin susceptibility testing
Updated Draft BASHH guidelines on the management of gonorrhoea indicate ciprofloxacin as preferential treatment over ceftriaxone if susceptibility is known. …
Continue ReadingSpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG
SpeeDx announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus MG. “This test is an …
Continue ReadingUK drafts new M. genitalium guidelines: Resistance Guided Therapy to tackle antibiotic resistance
The British Association of Sexual Health and HIV (BASHH) draft guidelines for Mycoplasma genitalium (Mgen) were posted for consultation and …
Continue ReadingABC Radio National – Catriona Bradshaw discusses the success of Resistance Guided Therapy for treating M. genitalium
In her interview with Dr Norman Swan on ABC Radio National Health Report, Dr. Bradshaw discusses a new successful treatment …
Continue ReadingUK BASHH M. genitalium guidelines updated to include macrolide resistance testing
Important updates to the UK BASHH M. genitalium management guidelines are taking the issue of antimicrobial resistance (AMR) seriously. The …
Continue ReadingClinical data demonstrates significantly increased cure rates using Resistance Guided Therapy for treating the STI Superbug M. genitalium
SpeeDx ResistancePlus® MG test supports new STI management guidelines SpeeDx Pty. Ltd. today announced clinical data contained in a new …
Continue Reading